ELEVATED RISK OF PAPILLARY THYROID CANCER IN KOREAN PATIENTS WITH HASHIMOTO'S THYROIDITIS

被引：125
|
作者：
Kim, Kyung Won [1 ,2 ]
Park, Young Joo [1 ,3 ]
Kim, Eun Hye [3 ]
Park, So Yeon [4 ,5 ]
Park, Do Joong
Ahn, Soon-Hyun [8 ,9 ]
Park, Do Joon [1 ,6 ,7 ]
Jang, Hak C. [1 ,3 ]
Cho, Bo Youn [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[2] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea
[6] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
[7] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea
[8] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea
[9] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Songnam, South Korea
来源：
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2011年 / 33卷 / 05期
关键词：
Hashimoto's thyroiditis; thyroid cancer; thyrotropin; thyroid-stimulating hormone; papillary thyroid cancer; STIMULATING HORMONE-LEVEL; DIETARY IODINE INTAKE; SERUM TSH; HIGH PREVALENCE; CARCINOMA; ASSOCIATION; MALIGNANCY; NODULES; POPULATION; MANAGEMENT;
D O I：
10.1002/hed.21518
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Background. Hashimoto's thyroiditis (HT) and higher levels of thyroid-stimulating hormone (TSH) have been proposed as risk factors for papillary thyroid cancer (PTC), but this issue is still being debated. The purpose of this study was whether HT was related to the risk of PTC over TSH. Methods. We enrolled 1329 patients (1028 with PTC, 52 with follicular thyroid cancer, and 249 with benign disease) of 1490 patients who underwent thyroidectomy. Results. The TSH concentration was not different among patients with PTC or benign disease. Our study showed that men (odds ratio [OR] 1.54; p = .049) and the presence of HT (OR 2.96; p <. 001) increased the risk of PTC. Moreover, HT was associated with multifocal cancer (p = .005) and smaller tumor size (p = .031), but it did not influence the extrathyroidal invasion or nodal metastasis. Conclusion. Clinicians who deal with thyroid nodules should pay particular attention to HT because it is a stronger predictor for PTC than other risk factors. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 691-695, 2011
引用
收藏
页码：691 / 695
页数：5
相关论文
共 50 条
  • [21] A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk
    Lai, Xingjian
    Xia, Yu
    Zhang, Bo
    Li, Jianchu
    Jiang, Yuxin
    ONCOTARGET, 2017, 8 (37) : 62414 - 62424
  • [22] Genetic relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto's thyroiditis
    Subhi, Ohoud
    Schulten, Hans-Juergen
    Bagatian, Nadia
    Al-Dayini, Roa'a
    Karim, Sajjad
    Bakhashab, Sherin
    Alotibi, Reem
    Al-Ahmadi, Alaa
    Ata, Manar
    Elaimi, Aisha
    Al-Muhayawi, Saad
    Mansouri, Majid
    Al-Ghamdi, Khalid
    Hamour, Osman Abdel
    Jamal, Awatif
    Al-Maghrabi, Jaudah
    Al-Qahtani, Mohammed Hussain
    PLOS ONE, 2020, 15 (06):
  • [23] The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease
    Zhang, Ling
    Li, Hui
    Ji, Qing-hai
    Zhu, Yong-xue
    Wang, Zhuo-ying
    Wang, Yu
    Huang, Cai-ping
    Shen, Qiang
    Li, Duan-shu
    Wu, Yi
    BMC CANCER, 2012, 12
  • [24] The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease
    Ling Zhang
    Hui Li
    Qing-hai Ji
    Yong-xue Zhu
    Zhuo-ying Wang
    Yu Wang
    Cai-ping Huang
    Qiang Shen
    Duan-shu Li
    Yi Wu
    BMC Cancer, 12
  • [25] Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients
    Liang, J.
    Zeng, W.
    Fang, F.
    Yu, T.
    Zhao, Y.
    Fan, X.
    Guo, N.
    Gao, X.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2017, 37 (05) : 393 - 400
  • [26] Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis
    Zivancevic-Simonovic, Snezana
    Mihaljevic, Olgica
    Majstorovic, Ivana
    Popovic, Suzana
    Markovic, Slavica
    Milosevic-Djordjevic, Olivera
    Jovanovic, Zorica
    Mijatovic-Teodorovic, Ljiljana
    Mihajlovic, Dusan
    Colic, Miodrag
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (08) : 1011 - 1019
  • [27] Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis
    Snezana Zivancevic-Simonovic
    Olgica Mihaljevic
    Ivana Majstorovic
    Suzana Popovic
    Slavica Markovic
    Olivera Milosevic-Djordjevic
    Zorica Jovanovic
    Ljiljana Mijatovic-Teodorovic
    Dusan Mihajlovic
    Miodrag Colic
    Cancer Immunology, Immunotherapy, 2015, 64 : 1011 - 1019
  • [28] Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto's thyroiditis
    Ohmori, Nariko
    Miyakawa, Megumi
    Ohmori, Kazue
    Takano, Kazue
    INTERNAL MEDICINE, 2007, 46 (09) : 547 - 550
  • [29] Is Hashimoto's thyroiditis a prognostic factor for thyroid papillary microcarcinoma?
    Bircan, H. Y.
    Koc, B.
    Akarsu, C.
    Demiralay, E.
    Demirag, A.
    Adas, M.
    Alis, H.
    Kemik, O.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (13) : 1910 - 1915
  • [30] Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis
    Min, Yu
    Huang, Yizhou
    Wei, Minjie
    Wei, Xiaoyuan
    Chen, Hang
    Wang, Xing
    Chen, Jialin
    Xiang, Ke
    Feng, Yang
    Yin, Guobing
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
12345